VAERS reports by lot

GSK DTaP/Tdap lot 9HP9Z: VAERS reports

33 VAERS reports list lot 9HP9Z as a GSK DTaP/Tdap vaccine, received between 2022-10-27 and 2024-09-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1544%
Allergic / Anaphylactic515%
Psychiatric / Neuropsychiatric515%
General / Systemic (non-local)412%
Gastrointestinal26%
Musculoskeletal26%
Neurological13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan7
California4
Ohio3
Washington2
Colorado2
Georgia2
Montana2
Missouri1
Massachusetts1
Pennsylvania1
New Hampshire1
Wyoming1

Reports by month received

2022-101
2022-121
2023-014
2023-024
2023-033
2023-041
2023-051
2023-062
2023-093
2023-101
2023-112
2024-021
2024-042
2024-056
2024-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.